CAR immune cells: design principles, resistance and the next generation – Nature
Alert Breaking News - US,
Abramson, J.
Abramson, J.
Auxolytic has developed a nutrient-based safety-switch for cell therapies that doesn’t rely on introducing transgenes.
The early success of CAR-T cell therapies in treating some forms of blood cancer has sent oncology researchers on a quest to…